FDA ODE III permanent director
Executive Summary
FDA's Office of Drug Evaluation III will be led on a permanent basis by Julie Beitz, FDA announces Oct 25. Beitz, formerly ODE III deputy director, has been acting director since former director Florence Houn went on detail to the Office of Compliance in January. Houn is now deputy director of CBER's Office of Vaccines. Divi-sion of Reproductive & Urologic Products Director Daniel Shames has been serving as acting deputy director of ODE III...